Protolabs Significantly Expands U.S. Metal 3D Printing Capacity

Protolabs has made a significant leap in its U.S. manufacturing capabilities, particularly in metal 3D printing, to meet the growing domestic demand for high-quality printed parts. As industries such as medical devices, aerospace, and defense increasingly adopt metal 3D printing for production applications, Protolabs has expanded its facilities and technology to enhance scalability and service a broader range of applications.

In 2025, Protolabs introduced four large-format, dual-laser Colibrium Additive M2 metal printers at a newly established Raleigh, N.C. facility. This facility is dedicated to direct metal laser sintering (DMLS)—a leading additive manufacturing process that allows for the creation of intricate, lightweight structures. The 120,000 sq. ft. factory hosts nearly 40 DMLS printers, boasting a production capacity of more than 8,000 parts each month.

To solidify its position in key sectors, Protolabs has also achieved ISO 13485 certification for its DMLS operations, alongside AS9100D certification for aerospace manufacturing. "Protolabs’ comprehensive additive manufacturing capabilities have made us the preferred partner for 3D-printed parts in the U.S.," stated Suresh Krishna, President and CEO.

The recent open house brought together leaders from the medical and aerospace sectors to explore how Protolabs' advancements can benefit their product development processes. According to Kenny Capps, director of 3D printing manufacturing operations, the combination of Protolabs' capacity, expertise, and reputation for speed and quality makes it an attractive option for businesses ranging from rapid prototyping to final production.

With ongoing innovations and improvements in materials and secondary operations, Protolabs continues to support industries in leveraging the design flexibility and material advantages of metal 3D printing without compromising on part quality for end-use applications.

Protolabs’ recent expansion of its U.S. metal 3D printing capacity marks a pivotal moment for the company, poised to yield significant market implications for investors. The installation of four large-format Colibrium Additive M2 printers at its advanced Raleigh facility is particularly strategic, allowing Protolabs to tap into the surging domestic demand for custom metal components across the medical device, aerospace, and defense sectors.

This multi-pronged strategy includes not only greater capacity but also a focus on industry-specific certifications like ISO 13485 and AS9100D, which will enhance Protolabs’ attractiveness as a trusted partner for businesses seeking quality compliance in highly regulated markets. Such qualifications boost consumer confidence and facilitate entry into more complex projects, thereby expanding potential revenue streams.

Investors should note that the combination of increased production capacity—estimated at over 8,000 parts monthly—and the company’s reputation for speed and efficiency presents a strong competitive advantage. This capability aligns well with emerging market trends toward additive manufacturing for end-use parts, providing a clear path for growth in an industry projected to expand significantly in the coming years.

Moreover, the focus on medical and aerospace applications is noteworthy, as these sectors are expected to continue adopting advanced manufacturing technologies to meet evolving demands. With Protolabs enhancing its suite of services beyond just printing—through engineering support and secondary services—it positions itself not just as a supplier, but as a comprehensive partner in the product development process.

Given these developments, investors should consider Protolabs a solid opportunity for portfolio diversification in high-growth industries. As the adoption of metal 3D printing accelerates, the company’s proactive initiatives are likely to yield long-term benefits and may provide a substantial return on investment. Keeping an eye on market trends and Protolabs’ advancements will be essential for making informed investment decisions.